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Objectiw. This study was designed to determine whether 
carbon monoxide has pmarrbythmic effects at rest and during 
upright exercise in patients with myoeardlal ischemin and madsr- 
ate baseline stopic activity. 
Backpund. Ewporure of patieats with docuawated myocar. 
dial ischemia to low levels of carboxybemeglobin (COHb) alters 
lhe myocardial rerpona to exercise. Anecdotal reports from 
patients with myoeardial ischemia have noted the development of 
nrrbythndas related to carbon monoxide exposure. Inereawl 
frequency olarrhythmias related to carboo monoxtde exposure in 
patients performing supine bicycle exercke has been recently 
rep&d. 
Mel/t&. Twenty-eight nowmaking men and live nonsn?&iig 
women with documented coronary artery disease and a z.kivom 
930 venkicular ectopic brats/h over a 20-h period were shldied. 
Subjects wax expd in a randomized double-blind fashion to 
either room air or sufficient carbon monoxide ta elevate their 
COHb mncenlralion to 3% or 5% in 1 h, followed by II nudnte- 
nance expwre to carbon monoxide. Tbe subjects tbn I& the 
laboratory and resumed (heir normat daily activity lo deter&e 
changes in ventricular ectopic beatr after carbon monoxtde expo- 
surl!. 
Resells. There was no sigaificaat change in the frequency of 
rlagteV@r~trlCul~fftOptC bfplS*L rest fiwm 115 f 28(iniomnair> 
IO 121 i 31 at 3% COiib to 94 k 23 at 5% COHb. Exercise it&f 
iwreued thefrqaeacy JI ventricular ectopic be&, but therewas 
w additimmt dfect ufearban munuslde exposure on the exercise- 
induced inQepJe in isolated e&pie beats or cnmpkx ectopk 
waveforms. Analysts oftbe data based on gmuping d the subjects 
by the sever& of dtsew (ventricutar ectepk beat kquacy. 
ejection fractt~+~, presence of ewrcb&uJuced tscbemia) tndicated 
M prorrrhytbmic i&&cl d carbon monoxbie. 
conrlrrcionr. In patttntF with frequent ventrteular eetoptc 
aettvity (230 cctoptc bcatrlh), exposure to carbon moaoxtde 
producing either 3% or 5% COHb dots not increase arrbma 
frequency of single or maltlple buts daring rest or exe&e. 
(I Am CoU Car&t 1993;21.ti2-50) 
Approximately 350,01Xl Americans die suddenly each year 
from a wide variety of cardiac causes (1;. Most sudden 
cardiac deaths are due to ventricular fibrillation, usradly 
preceded by ventricular tachycardia or high density ventric- 
ular ectopic beats as shown by the available ambulatory 
electrocardiographic (ECG) recordings at the rime of death 
(2). Concern over the health effects of air pollution raises the 
issue as to the involvement of pollutants in sudden cardiac 
death in susceptible populations. Epidemiologic studies 
(3) in Los Angeles have demonstrated a slightly increased 
mortality rate from myocardial infarction in relation to 
atmospheric carbon monoxide levels. Eighteen days of low 
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level exposure ID carbon rIIDnDY.ide has been shown to result 
in an increase in the frequency of arrhythmias positively 
correlated with carboxyhemoglobin (COHb) levels (4). Low 
levels of COHb have been shown to shorten the time to 
exercise-induced myocardial ischemia thresholds in patients 
with coronary artery disease (5). Cat&m monoxide exposure 
has provoked or aggravated cardiac arrhythmias in exoeri- 
menial animal preparations (a-81, as has&o been rep&ted 
(9-t I) for a few susceptible human subjects when COHb 
levels are substantially elevated. The impact of mild to 
modest levels of carbon monoxide exposure on cardiac 
arrhythmia frequency has not been thoroughly studied. 
Hinderliter et al. (12) studied t0 patients with ischemic heart 
disease and no ventricular ectopic activity during baseline 
monitoring. In these patients, ventricular ar hythmias during 
exercise testing or in the 5 h after exercise were not 
precipitated by carbon monoxide exposure resulting in 4% 
and 6% COHb. In a subsequent study, Sheps et al. (13) 
reported that 6% COHb in patients with coronary tiery 
disease and baseline arrhythmias resulted in a significant 
increase in ventricular ectopic activity and multiple ectopic 
beats during exercise. 
Carbon monoxide is a common pollutant to which pa- 
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tients may be exposed almost daily. The present study was 
designed to assess tne impact of low level carbon monoxide 
exposure in patients with evidence of coronary artery dir- 
ease who have demonstrated the potential fot frequent 
ventricular ectopic activity before carbon monoxide expo- 
sure. 
Methods 
Shuly patients. A total of 68 nonsmoking patients with 
ischemic heart disease and chronic ventricular arrhythmias 
defined as >3tl premature ventricular complexes/b avenged 
over 20 h were screened for enrollment in the study. To 
qualify as a nonsmoker, patients had to have smoked no 
cigs.reItes, pipes or crgars within the previous 90 days. All 68 
patients were retested; 35 did not meet the criterion of 230 
premature ventrict.!ar complexes/h averaged over 20 h dur- 
ing the repeat observation and were not enrolled in the trial. 
Patients were excluded if they had childbearing potential. 
severe renal or hepatic insufficiency. second- or third-degree 
atricventricular (AV) block, history of recent rest angina. 
severe ttncotttrolled hypertension. valvular hcrrt disease. 
decompensated congestive heart failure, intermittent claudi- 
cation, hemodynamically significant ventricular tachyar- 
rbvthmias or serious intraventricular conduction delnvs. 
Patients with an artificial pacemaker. left bundle branch 
block or atrial fibrillation were also excluded because these 
cottditions interfere with ECG arrhythmia analysis. Anti- 
ischemic and antiarrhythmic drug therapy was permitted and 
the dosing and timing of ingestion were constant on each test 
day. 
There were 33 patients (28 men and 5 women) who gave 
informed consent and participated in the randomized trial. 
Three of these 33 patients were removed from analysis: one 
patient was unable to complete the series of test days. one 
had ambdatory ECG data that was uninterpretable and one 
failed to meet carboxyhemogiobin (COHb) entry criteria. 
The study group consisted of the remaining 30 patients 
(Table I). The average age of the patients was 65 years 
(range 45 to 77). Of tl,~ 30 patients, 28 had angiographic 
evidence of coronary artery disease; in the remaining 2 
patients the diagnosis of ischemic heart disease was made on 
the basis of a previous history of myocardial infarction or 
abnormal exercise ECG plus evidence of a thallium defect. 
Car&active medications, ejection fraction and the presence 
or absence of exercise-induced angina or ST segment 
changes on the screening exercise test are listed in Table 1. 
Experiwntal pmtoml. The protocot was approved by 
the Saint tottis University Institutional Review Board and 
informed consent was obtained from each patient. A l-week 
window was permitted between the screening study and 
entry into the protocol, at which time a complete history and 
physical examination, Il-lead ECG, chest X-my film, rou- 
tine biochemical screen, differential hematologic study, ve- 
nous COHb determination, carbon monoxide uptake rate, 
spirometry. echocardiogram and treadmill exercise test were 
obtained. During this week, patients were shown the envi- 
ronmcnral chamber and were familiarized with the test 
conditions. Three days of tes!Ing with a maximum of7 days 
and a minimum of 2 days befwccn test days permitted 
double-blind randomized exposure to either room air or two 
levels of carbon monoxide with minimal carryover of effects 
from a previous experiment. The subject, physician and 
nurse who supervised the exercise test were blinded to the 
test condilions. Continuous 20-h ambulatory ECGs were 
obtained with the recorder placed on the patient 2 h before 
car&n monoxide exposure. A maximal symptom-limited 
exercise test was performed with a modified Naughton 
protocol after maintenance COHb levels were reached. 
Carbon mmtuxide expmure ~ralac&. Ambient carbun 
monoxide m our environmental chamber is ~4 ppm. Levels 
of COHb were determined from venous samples by gas 
chromatography (14) at rest before and during cat-bun mott- 
oxide exposure and after exercise during carbon monoxide 
exposure. All personnel other than the chamber operator 
were blinded to the randomized order of the chamber carbon 
monoxide levels. Nonsmokers were rattdomfy exposed to 
either room air or carbon monoxide at two dierent levels to 
produce 3% (low) or 5% (high) COHb levels after 1 h of 
exposure (15). The level of carbon monoxide was assessed 
from pretest uptake rates determined in the week preceding 
randomization. After fdl min of exposure, the chamber level 
of carbon monoxide was lowered to 0 to 35 ppm of carbon 
monoxide to maintain the peak percent COHb for an addi- 
tional ‘90 mitt, which included the exercise and immediate 
postexercise phase (16). The treadmill exercise test was 
performed after M) min of equilibrium exposure. Wwd 
samples were taken to verify the body burden level of carbon 
monoxide during the uptake and steady state phase of 
exposure at 40,60,90 and 120 mitt and tier exercise. 
Each patient had an indwelling venous catheter inserted 
on arrival at the labomtory and a pnz-exposure biood sample 
was drawn and analvzed immediatelv hv usina an IL-282 
CO-oximeter &bra&d with samples .&,aiyzed cy gas cltro 
matography to estimate the percent COHb. If the COHb 
level was below the equivalent of I% by gas chromatogra- 
phy, the subject continued the protocol. If this criterion for 
exposure level of CGHb was not met, the experiment was 
discontinued and rescheduled. A 72-h window was used to 
reenter such patients into the protocol. However, subjects 
who failed retest conditions were considered to have 
dropped out. 
To obtain an adequate assessment of baseline arrhythmia 
frequency, the exposure day protocol (Pig. I) specifically 
included a 1213min period of rest before any exposure and a 
a6C-min period dnring which the blood level of farboa 
monoxide remained constant with the subject at rest. The 
use of a steady state period enabled the evaluation of the 
effect of a fixed level of COHb on arrhythmia frequency at 
rest during a reasonable period of titne. The sampliug 
interval to assess the impact of carbon monoxide exposure 
on cardiac arrhythmias during treadmill exercise mnged 
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Table 1. Clinical and Baseline Chamcleristics of the %udy Patients 
PI Age h)l 
NO.’ Gender CAD hl1 Medications EFI *“pa, ST 
Arrhythmia Profile 
Meas Paired Beats1 Total 
VEBlHour 20 Hours V-r,20 HOW! 
I 
2 
3 
4 
5 
7 
9 
IO 
II 
12 
13 
I4 
IS 
16 
17 
18 
19 
20 
21 
22 
23 
25 
26 
27 
28 
21 
30 
31 
32 
33 
75lM 
7OlM 
6lfM 
62~?J 
611M 
7om 
54/M 
69iM 
65iM 
b71M 
51iM 
671F 
IOIM 
5llM 
,I/?4 
51% 
l%fM 
711F 
70/M 
74,F 
65iM 
67/F 
77,t.i 
67iM 
61/M 
7oiM 
64/M 
MIF 
6w.i 
45/M 
2 
I 
1 
_ 
- 
I 
2 
I 
I 
I 
3 
2 
3 
I 
I 
I 
2 
I 
3 
3 
2 
3 
I 
t 
2 
3 
I 
2 
t 
3 
N 
N 
AA 26 
Nit. CaB 58 
N 
I’ 
CIB 58 
BB 66 
Nit, CaB 49 
Dig 25 
I%, AA. Dig 32 
CaB 55 
BB. CaB. AA, Dig 38 
No Anti-at@ 39 
88, can. AA 41 
CaB 71 
CaB 55 
BB 44 
No *no-ang s5t 
Nit. 01s 
Dig : 
Gl3 46 
No Anti-aq 33 
BB, Dig 43 
88 59 
CaB, Nit 32 
Dig, AA 4s 
CSB 
Dig f 
No Aoli.ang 31 
CaB 55 
BB 53 
BB,Q 39 
N.l.2 mm 
Y, 
N. 
NJ0 mm 
N 
N 
N2.3 mm 
N 
N 
N,1.2 mm 
N 
; 
N 
N 
Y 
N 
N 
N 
N 
Y 
N 
Y 
N 
Y 
Y 
N 
N 
N 
Y 
N 
N 
Y 
N 
Y 
N 
N 
N 
Y 
Y 
Y 
Y 
Y 
N 
Y 
N 
N 
Y 
N 
41 
59 
148 
74 
45 
321 
37 
s7 
34 
1% 
a2 
31 
31 
65 
253 
61 
12 
6h 
39 
53 
45 
174 
to3 
36 
2w 
51 
14s 
so 
795 
44 
44 
” 
118 
16 
208 
22 
8 
362 
Ia 
6 
a 
a 
240 
II 
0 
14 
ZI 
0 
0 
N 
NJ.5 mm 
N 
NJ.8 mm 
r: 
N 
N.l.8 mm 
N.1.3 mm 
N 
34 
46s 
0 
252 
16 
18 
30 
718 6 
Y DiE 32 N 55 26 0 
*Patients 6. e and 24 were excluded Lwcaw or technical reasons (see tent). Weeion fraction (EF) determined by cpotmst ventriculography. AA = 
anGstthythmic agent; Ant&g = anrianginal medicaiion: BE = bela-sdrenwgic blocking a ent; QB = calcium channel blocker; CAD = number of ~omnsty 
arteries with ~70% lumen narrowing; Dig = digitalis; F = female; M = male; MI = myocardial infarction: N = no: Nit = nitralc; R = wtient; Sf = hwizcutsl 
from 3.75 to 18.5 min. Arrhythmia frequency was monitored 
during the 6-h postexposure phase when the subjects fol- Figure 1. The relative duration (in minutes) of each phase of the 
lowed their normal daily routine but still had elevated COHb ambulalory electrocardiographic monitoring period. Subjects 
levels (bused on known rates of carbon monoxide elimina- breathed either one of two levels of carbon monoxide (CO) (hatched 
tion) and for the approximate 10 h of remaining ambulatory 
and cross.batcbed hsws) or room air (solid bars) under double-blind 
ECG recording when the body burden of carbon monoxide 
conditions. The limes shown reflect the average limes for di 30 
had returned to within the limits of normal. 
subjects. COHb = carhoxyhemot$obin. 
Measurement of carbon monoxide in blood. The effective 
carbon monoxide dc:e each subject received during the 
protocol exposure phase was based on carbon monoxide 
blood levels. The primary measurement of the amount of 
carbon monoxide bound to hemoelobin was made bv errs 
chromatography (11,15). For oper&onal purposes, immidi- 
ate estimation of COHb levels was required; this was ac- 
complished with the use of an IL 282 CO-oximeter. 
Exorcise R-Xovs~ 
Chamber carbon monoxide concentration. The chamber 
carbon monoxide level that the subject inhaled during the 
entire visit to the laboratory was conGnuously monitored. A 
sample line was placed near rhe subject’s head for the 
0 100 200 300 4DG 530 600 700 
Dum#+n Imio”*l, 
measurement of carbon monoxide with the use of a nondis- 
persive infrared analyzer (Bendix model SOL-5CA). Before 
sub&t monitarine each dav. the analvzer was cahbraied . 
using Environmental Protection Agency standard gases 
traceable to NlST (National Institute for Standards and 
Technology) standards for carbon monoxide (AIRCO). 
Arnbulstury ECG technique. The continuous 20-h ambu- 
latory ECGs were obtained on a portable three-channel 
recorder with electrodes placed in a bipolar V, and V3 
position. The recordings were acquired with Avionics re- 
corders (model 4591 and analyzed on an Avionics 
Trendscriber (model 9100). permitting individual program- 
ming of a multifactorial computer for recognition of pro- 
grammed templa:e configurations of normal and ectopic 
beats. Each recorder had an event marker that indica:ed 
critical time Points during the experimental exposure (Fig. 
I). A hard copy of each ambulatory ECG was obtSned with 
a fiber optic printer and ventricular arrhythmias on the real 
time printout were manually coonbed. All vcntriculnr ar- 
rhythmias on the recording were manually counted except 
for those in the last phase of the recording, which started 6 h 
after exercise was complete. Ventricular arrhythmias during 
this last phase of ihe recording interval were analyzed by 
computer unless there was a discrepancy between the corn- 
puter measurements and the manual counts for the subjects 
during the previous periods. This occurred in two patients in 
whom ihe last phase was also manually counted. Validity 
assessment defined on a stratified manually counted 150-h 
ven..lcular ectopic beat data base and a 50-h supraventricu- 
lar ectopic beat data base determined a posilive predictive 
accuracy of 94%. a sensitivity of 92% and a false positive 
rate of 6% for ventricular ectopic beats. The data o5:aincd 
included an hourly count of total premature ventricular 
beats, ventricular coup:cts and nonsustained (~30 s) and 
sustained ventricular tachycardia. 
Exerefse testing. A modified Case 12 Marquette system 
was used to acquire multiple lead ECG data. Arrhythmia 
frequency was also assessed during the exercise test using 
the continuous ambulatory KG. The exercise te.sl used a 
symptom-limited modified Naughton protocol. The presence 
of severe fatigue, dyspnea, dizziness, malignant ventricular 
arrhythmias, marked ST segment depression from baseline 
(~0.3 mV), decrease in systolic blood pressure of 20 mm Hg 
compared with the preceding reading and progressive angina 
were indications for test termination. The presence of isch- 
emit ST segment depression (horizontal or downsloping ST 
segment depression ~0.1 mV compared with baseline) oc- 
cur& in nine patients (Table 1). Appropriate medication 
and an eIecectric defihrillaror were immediately available oot- 
side the chamber and an intravenous line was inserted in all 
patients before the experiment. The environmental chamber 
waslocated within the Cardiology Division at the University 
Hospital. 
Data analysis. The primary aim of this study was to 
determine whether carbon monoxide exposure rcsultjng in 
3% and 5% COHb levels by gas chromatography bad a 
significant onpact on total and repetitive ven~ricul~ arrhyth- 
mia frequency for four specific time interva!s: I) 2 h ofres~ 
during exposure; 21 during exercise: 3) 6 h after chamber 
exposure [carbon monoxide unloading); and 4)the remaining 
recording interval (approximately IO hl. Exercise-induced 
ventricular arrhythmia frequency was a primary end point. 
Tie total number and type of ventricular arrhythmias re- 
corded during the 5 min before exercise, during exercise and 
during the 5-min postexercise phase were analyzed from the 
Marqucttc system records. The exercise level was similar on 
each of the 3 days of testing. However, to adjust for the fact 
that exercise time was not precisely the same on each of the 
3 days. ventricular arrhythmia count rates were adjusted for 
total exercise duration to provide an hourly ventricular 
ec!opic beat rate. 
Differences in average hourly heart rate. nilmbcr of 
premature ventricular beats, repetitive forms and episodes 
of nonsuslained and sustained venrricutii rachyarrhythmtas 
were compared using a two-way analy+s of variance 
(ANOVA) (17). Initial plots of veetricular ectopic beats 
indicated doal Ihe data were not normrd!y distributed: there 
were ootliers and the data were skewed. Therefore, we used 
Friedman‘s analysis of variance for repeated measures (18). 
which is a nanparametric equivalent to a two-way ANOVA 
for this design and is an extension of the sign test for more 
than two matched groups. Friedman’s test was used for the 
posthoc pairwise multiple comparisons. There data were 
also analyzed using parametric stafistical methods on both 
transformed data (tog) and group mean values of the imiivid- 
ual differences between ventricular ectopic beatsih for each 
period corrected for daily pre-exposure values. 
For each of the three COHb conditions, Friedman’s test 
was used to identify any staiistically significant differences 
on the number of ventricular ectopic beatsih during each of 
the specified time intervals. The analysis was performed 
with use of all 30 subjects and was repeated after slratifica- 
tjon by ejection ftaction (GW%, n = 13; = 40% n = 17). 
Similar analyses were stratified by the number of ventricular 
ectopic beats/h at baseline and the presence or absence of 
exercise-induced chest pain or abnormal exercise-induced 
ST segment depression. 
POWW catculationr. Determination of the statistical 
power necessary to evaluate the differences between the 
measurement perinds and between conditions was carried 
out for simple pairwise comparisons for the primary hypoth- 
eses. Pairwise comparisons for steaGy state and exercise 
values among the three conditions were used. The Power 
calculations were made usioga paired I test with a correction 
in the alpha level for multiple comparisons. The number of 
sobiects included in the studv orovided aooroximatelv 80% 
,ier to detect a change oiSb ventric& ectopic beat& 
from the exercise level. Thus, small but significant differ- 
ences on the impact of ventricular ectopic activity may have 
been missed in the present series because of relatively smalt 
sample size. 
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Results 
The average COHb level on tbe 3 days of testing was 
0.7%, 3.2% and 5.1% for roomair, target 3% (low) and target 
5% (high) COHb. respectively. To achieve the average 3.2% 
COHb level, expusure to a mean (23D) carbon monoxide 
concentration of 159 * 25 ppm during the rapid uptake 
period and 19.3 + 0.8 ppm during the steady state period was 
required. The average 5.1% CClHb levels required exposure 
to 292 + 31 ppm of carbon monoxide for rapid uptake and 
31 f 1.2 ppm for steady state mainteaance. 
Ventricular arrhythmia frequency at rest. The mean um- 
ber of ventricular ectopic beats/h durir; all mca~urement 
periods when the subjects were at rest (seated) is shown in 
Figure ‘2A The I~.tions cf the aeiods were 133 min of rest 
before exposure, 60 min of ca&on monoxide uptake and 
60 min of COHb equdibrium. There were no significant 
differences in ventricular ectopic beats/b between the days 
for any of these periods at rest. Data from these measured 
periods did not include data obtain-d during intermittent 
periods of exercise, as occurred in the later periods when the 
subjects were ambulatory. 
Ventricular arrhythmia frequency oil dilferent test days. 
The mean number of ventricular ectopic beats/h was similar 
at baseline and on each of the 3 days of testing (Table 2). In 
the aggregate, there were no significant differences in the 
mean number of ventricular ectopic beats/h during the 
carbon monoxide equilibrium phase, the carbon monoxide 
unloading phase and the remainder of the recording interval, 
although there was a trend toward a decreased number of 
ventricular ectopic beats/h at the highest carbon monoxide 
exposure level (Table 2). When ventricular ectapic beats/h 
were analyzed by using each patient’s response to the 
randomized air exposure as the subject’s own control, there 
was also no evident pattam of response due to carbon 
monoxide exposure. Attempts to identify a susceptible sub- 
pup of subjects who responded consistently to carbon 
monoxide were also unsuccessful for both single ventricular 
ectopic beats and multiple atrhythmias. 
Effect of baaliie ventricular arrhythmia frequency (Tabk 
3). The data showing the impact of carbon monoxide expo- 
sure in patients stratified by low (<M) ventricular ectopic 
beats/h) and high (~60 ventricular ectopic beats/h) arrhyth- 
mia frequency on the baseline ambulatory ECG are pre- 
sented in Table 3. There were no significant differences in 
ventricular ectopic beat frequency after carbon monoxide 
exposure regardless of the level of ventricular ectopic activ- 
ity at baseline study. 
Exercise-btduced ST segment depression or angina al base- 
line. The effect of both levels of carbon monoxide exposure 
compared with room air was examined in patients stratified 
by presence or absence of exercise-induced ischemic ST 
segment depression or angina at baseline. There were no 
significant differences between room air and carbon monox- 
ide exposure for the different activity intervals regardless of 
Flgure 2. A, Frquency of isolated ventricular ectopic be& (YEB) 
corrected For time and rrresented as number of such beats 1xr hour 
(HR) for each of the r~domized exposure conditions. Thi values 
shown arefortheconditinns when the subject remainedcomfortably 
seated for the dumtion of these pe.riods. Values are expressed as 
mean value 2 SEM. The Mid airs rey-csent values fo; room air 
exposure: diitml hatching represents 3% carhoxyhemoglabin 
(COHB) target wosure values: iwrim&l batcbb~ represents data 
from 5% carboxvhemoalobin target exuosurcs. There were no ._ _. 
significant diffcressrs aman; any of the exposure conditions. 
Ft. Freauencv of irdated ventricular ectooic beats corrected for 
liine. Ttie p&exercise period was taken ovei a Wmin period during 
the steady stale exposure condition from ths ambulatory eleclrocar- 
diographh;c (ECG) monitoring dala. The exercise and 5-min exercise 
recovery data were obtained from the continuous EICG record. 
Exposure conditions are noted in panfi A. There werr no significant 
differenccr among any of t1.c exposure conditions. CO = carbon 
monoxide. 
whether exercise-induced angina or ST segment depression 
was present. 
~&ion fraction at base& (Table 4). The effect of both 
levels of carbon monoxide exoosure cornoared with room air 
was also examined in pati&ts strati&d by an ejection 
fraction <O&I or ~0.40. There were no significant differ- 
eaces between room air and carbon monoxide exposure days 
for the different intervals measured regardless of a relatively 
low eiection fraction (4.40) and normal or mild imaairment 
of I& ventricular function (ejection fraction >0.4oi 
Exercise test analysis (Tabk 5). There was no effect of 
carbon monoxide exposure on the frequency of exercise- 
induced ventricular ectooic beats at either level of carbon 
monoxide exposure (Fig: 28). The l&Is of COW used in 
this study had no e&t on the heart rate or systolic blood 
pressure rcspmsc iir exercise. 
Paired venkicular ecmpic be!Gs ad iiGiiG%Rd vcntric- 
uJar tachycxdia. The frequency of ventricular couplers and 
nonsustained ventricular tachycardia was similar in patients 
exposed to room air or to low and high levels of carbon 
monoxide (Table 6). At rest before carbon monoxide expo- 
sure on the day of 51% COHb, the number of repetitive 
ventricular ectopic bears was significantly tower in these 
subjects than on the day before the air exposure procedure. 
This difference at baseline is retkcted by a trend for all of the 
values to be lower for repetitive ventricular ectopic beats 
during each period of exposure to 5.1% COHC. although 
none of the values reached statistical significance. To adjust 
for the difference in baseline frequency of repetitive vent& 
alar ectopic beats. rhe basel$c m:Piiicmeots were sub 
tracted from each of the subsequem phases. There were no 
Pigmficdor UTciences in Lc frequency of rcperitive &,entric- 
ular forms before or after adjustment for baseline frequency. 
Disclsssian 
The main finding in .ilis study is that carbon monoxide 
exposure producing 3% and S% carboxyhemoglobin (COHb) 
levels as determined by gas chiomatognpkj d2 not result in 
a proarrhythmic effect during normal daily activity as mea- 
sured on the ambulatory and exercise ECG. These findings 
are in generzd agreement with recent reports t19-21) on the 
potential for proarrhythmic effects of carbon monoxide in 
animal models of ischemic disease. Vanoli et aL (i9) studied 
Table 3. Effect of Carbon Monoxide Exposure on the Number of Ventricular Ectopic BcatsIHour 
Arcordicg to Each Aaivity 
-.-. -_ 
Activity Period 
Subjects with a&U VEBi (n = ISI 
Baseline 
co lcadtng 
COHb skadu stak 
0.7% 3,:s 5.1% 
27.2 r 19 2 33.3 * 21.7 37.3 5 38.4 
26.4 f 24.5 17.7 + 30.7 31.2 * 14.9 
41.8 + 15 4 49.7 t 41.8 40.9 t 31.1 
Exercise 70.8 f 86.6 117.9 t 174.1 41.6 + 44.1 
Exercise recovery 1S.l f 210.6 173.7 2 222.2 226.3 2 341.4 
CO unload 
Remainder 
Subiec& whh >&I VEWb (n = IS) 
Baseline 
CO lcadinp 
COHb rte& state 
Exercise 
Exercise ~c0~4ry 
CO unload 
Remainder 
54.5 t 37.3 52.0 + 1.5 so.1 t 5u.o 
39.5 * li i 12 I f 24.0 35.1 + 31.0 
204.9 ? 237.4 202.6 k 218.6 177.4 f 228.1 
iw.3 t 28.6 173.4 t 174.2 X.6 = 13p.4 
189.0 f 187.9 192.7 * ?KS 146.8 ‘+ lbS.1 
18.6 + 468.2 394 0 c 470.1 X9.9 ? 338.5 
JW.2 + 593.8 531.7 + 754.2 37J.9 * 413.5 
313.3 f 311.6 135 I + 3w.x 30.3 = 23.5 
223.4 ? 341.5 241.3 + 279.8 222.9 * 369.9 
Table 4. Effect of Carbon Monoxide Exposure on the Number of Venlricular Eclop;c BeatslHaur 
Accordiug to Each Activity Period Stratified by Baseline Ejection Frac!k 
YEWHour According lo % COHb 
Aclivuy Pencd 0.7% 
~~ 
Subjects with ejection fraction <40% (n = 131 
Bsselinc 188.6 + 263.4 
CO loading 182.1 f 273.Y 
COHb steady state 180.4 ‘- 205.9 
Exercise 287.8 + 460.1 
Exercise recovery 318.3 f 310.1 
CD unload 265.7 + 352.5 
Remainder 240.8 f 367.2 
Subjects with ejection fraction >4@% (II = 17) 
Bareline 6Q.s 2 6x6 
CO loading 55.5 i 64.4 
COtlb steady SW 65.7 f 65.7 
Exercise 142.9 e 213.1 
Exercise recovery 417.8 I 598.1 
CO ““Inad 121.4 e 111.6 
3.2% 5.1% 
173.5 + 231.45 156.8 t 252.2 
I6O.J 2 194.7 118.5 f 136.4 
170.0 f 236.2 137.9 f 177.1 
222.8 f 297.4 161.6 + 221.4 
193.8 * 211.3 284.6 z 343.2 
241.8 f 157.2 219.2 + 261.6 
210.9 t 316.7 228.4 + 337.1 
7J.S L IO5.I 69.6 r 69.3 
63.7 + 57.2 62.7 2 76.5 
8.9 f 87.4 MI.1 f 69.3 
281.1 + 411.2 169.6 f 306.3 
474. I t 729.0 310.1 + 415.8 
156.6 2: 153.8 123.9 * 108.4 
Remamder 41.9 ? 38.2 .#o.o 2 79.9 53.0 f 44.6 
‘9 c 0.05 for baseline versus activily levels; p > 0.05 Lr baseline verru$ aclivity I~wIs far all Mher data in 
columns. p > O.OSforlhe comperirotl of0.7%vcnus 3.2%and 0.7% verrusS.l% carboxyhemoglabin (COHb)fevels 
for dala m rows. Values are reported as mean value f SD ior all M study patirna. Abb:eWionr a5 in Tabk 2. 
the effects of 10% COHb in dogs 30 days after anterior 
myocardial infarction and reported no increase in malignant 
arrhythmias in awake animals exposed to carbon monoxide. 
In a study of both conscious and anesthetized dogs with and 
without &hernia, COHb levels of up to 2ti had no acute 
effect on electrical stability of the myocardium (20). Foster 
(21) also reported that 10% COHb had no effect on ischemic 
myocardial electrical conduction created by 6 min of occlu- 
sion of the left anterior descending coronary artery in dogs. 
The negative proarrhythmic effects of carbon monoxide in 
the animal models were not predictable on the basis of the 
reported positive effects of carbon monoxide on myocardial 
conduction velocity. Carbon mnoxide has been shown to 
decrease fibrillation threshold in monkeys after infarction (6) 
and in dogs (8) after left anterior descending coronary artery 
ligation. In addition, carbon monoxide has been reported to 
increase ventricular arrhythmias in dogs with digitalis- 
induced ventricular tachycardia. 
In human studies that have specitically investigated the 
etiects of carbon monoxide on arrhythmia frequency, low 
levels of COHb have been shown to have no effect in 
subjects with coronary artery disease at rest whether they 
have baseline ectopic beats (present study, 13) or do not 
(12). 
Clinical signiliermce. The study patients selected in the 
present series had well documented coronary artery disease 
and were selected for inclusion on the basis of chroriic 
ventricular arrhythmias 2 30 ventricular ectopie beats. In 
the early posiinfarction phase, hii density ventricular ec- 
topic beats and nonsustained ventricular tachycardia on 
predischarge ambulatory ECGs have heen reported to be 
associated with an increased incidence of cardiac events. In 
our study, we excluded patients with recent myocardial 
infarction, unstable angina, sustained ventricular taehycar- 
dia and ventricular ectopic activity with hemodynamic insta- 
bility. Of the 30 patients studied, 10 had a previous history of 
myocardial infarction, 7 of whom had an ejection fraction 
<40%, and I2 patients had nonsustained ventricular tachy- 
cardia at baseline. The patients in the current protocol 
represent a prognostic intermediate group, in whom a low 
level of carbon monoxide exposure did not result in wors- 
ening of their ventricular arrhythmias as measured by am- 
bulatory ECG and exercise testing. The potential effects of 
low level exposure to carbon monoxide on impulse conduc- 
l’abk 5. Group Average Hean Raw and Systolic Blood Pressures During the Exercise Period of Arrhythmia Monitoring 
-- 
Rwm Air Low COHb High COHb 
(0.7% COB) W% COHb) (5. I% COHb) 
HR SW HR SBP HR SBP 
Activity Period Condition (beatsimin) (mm Hd lbeatslminl lmm Hgl (btuslmin) (mm W 
Before exercise RWl 90.0 f 14.8 131.7 f 19.7 91.6 + IS.9 129.5 k 21.9 92.6 Z 16.4 127.6 5 19.5 
Exercise test Maximal exerc~x 126.3 f 20.8 171.7 f 23.5 110.1 + 23.0 169.5 ? 26.0 129.6 f 24.1 168.3 * 27.5 
Values are ;eporled as mean value k SD for all 30 study patients. COHb = carboxykmoglobin; HR = heart rate; SBP = syllolic blocd pressure. 
‘Iable 6. Effect of Carbon Monoxide (CO) Exposure on the 
Sum of Paired Ventricular Beats and Nonsu~lamed 
Ventricular Tachvcardia 
Events/Hour According to 
I Carbnrvhemoelobin 
Activily Period 0.7% 3 2% s.Fc 
Baseline 143 = 31.6 10.0 z 24.4 5.7 t 14.7’ 
CO loading 10.8 z 26.1 iz.2 t X.4 7.4 t 16.4 
COHb sleady slate ID.8 t 21.0 11.5 f 29.4 I”.8 : 22.3 
EWCi% 45.1 r 134.0 ,I.6 + 74 0 17 9 -. 41.3 
Exercire recovery 62.2 -c 126.5 32.6 f 65.8 52.9 L 130.6 
CO unload ?A.! * 51.2 19.4 5 II 6 14.4 * 30 4 
Rcmaindar 10.6 t 26.9 II.7 2 28.S 9.9 z 20.4 
l S~fican~di&rencefromO.l~cEarboxyhemo~~bin (COHo)level% p < 
lI.05. Values are repaned as mean ? SD far the sum of evemr $; hour 
according to each aclivity period lot all 30 rludy pal&h. The wcnts nrrr 
weighed according to x2 far couple:s and x5 far nunuslninrd vrnkieular 
tachycardia. 
tion characteristics were not measured in this series by 
electrophysiologic studies. 
According to estimates bythe Environmental Protection 
--. Peency, a typical adult involved in moderate activity would 
ha;e‘zi XXh level of approximately 2% after a l-h exposure 
to carbon monoxide a: 35 ppm [National Ambient Air 
Quality Standard [NAAQS]. I-h sisndard). Results from 
exposure models estimate that 60% of patients wiih cardio- 
vascular disease would have higher levels of COHb. The 
levels ofCOHb in the subjects during the steady-state period 
were elevated to levels that exceed the upper level of 2% 
COHb that most individuaIs would reach with either an 8-h 
exposure to 9 ppm or a l-h exposure to 35 ppm (current 
NAAQS standards). The 3.2% and 5.1% COKb levels as- 
sessed in the present study are similar to the levels studied 
by Sheps et al. (13) in patients with chronic ventricular 
arrhythmias. Similar low levels of CGHh have also been 
used in a recent study (4) of 63 men with documented 
coronary disease, exertional angina and exercise-induced 
myocardial ischemia. In that study (4), the time to develop- 
ment of ischemic ST segment depression after exposure to 
carbon monoxide resulting k 2% and 3.9% COHb levels 
was significantly decreased by 5.1% and tZ.l% percent. 
respectively, when compared with values obtain on the 
control day (4). Thus, low levels of carbon monoxide are 
recognized to have an adverse effect on patients with chronic 
stable exertional angina and documented coronary artery 
disease. 
Our findmp are in contrast to recently published infor- 
mation (13) specifically dealing with potential arrhyrh- 
mogenic effects of carbon monoxide, in which the frequency 
of isolated and multiple ventricular ectopic beats/h during 
exercise was significantly greater in subjects with a 6% 
COHb level than at 4% COHb or 0% COHb (room air 
exposure). Ventricular arrhythmias are to some extent ran- 
domly occurring events, and the shorter the measurement 
interval. the larger the measurement variability (22,23). 
Exercise is a known mressor that CXI increase ventr&dar 
arrhythmia frequency, particularly in the immediate postex- 
ercise phase as was demonstra:ed in the ptesent study 
(Tables ? and 6). There are important clinical differences in 
patient pclection between the study of Sheps et al. (13) and 
our study that may have accounted for the different findings 
during exercise. In the prcsem series, the percent of patients 
who had ?jO ventricular ectopic beats& was significantly 
greater and ventricular funcrion was signiticantly worse, 
resultmg in a shorter average time of exercise in the present 
study. The percent ofpatients who had myocardiaI ischemia 
as evidenced by exercise-induced angina or ischemic ST 
segment depression was greater in their study (13) and a 
greater percent of patients were taking beta-adrenergic 
blocking drugs. Myocardial ischemia is a weil known cause 
of ventricular arrhythmias and can exert a proarrhythmic 
effect. We analyzed our own data that stratified patients by 
the presence or absence of exercise-induced argina or 
exercise-induced ST segment depression ~1 mm and did not 
find a significant increase in ventricular arrhythmia frc- 
quency whether or not the patient had exerck-induced 
angina or ischemia atbaseline. Inthe report of Sheps et al. 
(13). COHb levels were determined with an IL 282 CO- 
oximeter. an instrument that is known to be inaccurate at 
low levels of COHb (15). This may account for an averace 
rest value of 1.8% COHC, a level that might be expected in 
a moderate smoker as determined by a more acctttze 
method. In the present report. the COHb levels that were 
used in the daua analysis were determined by gas chroma- 
tography. 
The ambulatory ECG recording during normal daily ac- 
tivities records multiple episodes of exercise and other forms 
of stress during daily activities and may provide a more 
meaningful &mate of the impact of carbon monoxide on 
ventricular arrhythmia frequency. To adjust for ventricular 
arrbythmia variability, we performed a iwo-way ANOVA, 
comparing data from the same patient at baseline on each 
test day (2-h preexposure phase) to results obtained during 
subsequent phases of the protocol. Furthermore. we cum- 
pared across time intervals for exposure days to the room air 
day to detect whether any signiftcant dtierences occurred. 
We were unable to demonstrate a significant difference in 
total veutrictdar ectopic beat counts or complex ventricular 
ectopic activity at 3.2% and 5.1% COHb levels durinb 
normal daily activities and during and immediately after 
symptom-limited exercise. 
Conclusions. Carbon monoxide exposure resulting in 3% 
and 5% COHb levels did not demonstrate a proarrhythmic 
effect during normal daily activity as measured by ambula- 
tory ECG and exercise ECG studies. The findings confirm 
the report by Hinderliter et al. (12) in patients with ischemic 
heart disease and no ventricular ectopic activity and the data 
of Sheps et al. (13) for the nonexercise protocol phase. 
450 w.HMS ET AL. JACC Vol. Lt. No. 2 
FXGARRHYTHMJC WTENTlAL OF CARBUN MONGXJDE Fcbrvw 1993:442-50 
References 
1. Akhtar hf. Gamn H. Lchmann MH. Troup PI. Sudden cardiac death: 
management ofbigh.risk palieds. Ann lntem Med 1991;114:499-512. 
2. Panidis IP. Morpanmlb 1. Sudden death in hospitattid pticds: cardiac 
rhythm disturbances ddtcted by ambulator, rlcclmczdiogmphic moni- 
tonng. J Am Coil Caniiol lP832:7%t705. 
3. GoldrmithJR, Landaw SA. Carlmn monoxide and human he&h. Science 
1968:162:1352-9. 
4. Aflied EN. Bfereker ER, Chaitman ER. ef d. Sbon-term cffecis of 
carbon monoxide exposure on the exercise prfarmana ~frubjecu with 
coronary artery disease. N Engl J Mrd 1’%9;321:1426-32. 
5. Davies DM. Smith DJ. Electrocardiographic changes in healthy men 
during continuous low-level carbon monoxide exposure. Environ Rcs 
198031:197-206. 
6. Kaul ft. Calabro J, Hulchean DE. EtXcta ‘of carbon monoxide on the 
vulnerability of the ventricks to drug induced anhylhmias. 1 Clin 
pbarmacol lP7~14:25-31. 
7. Debias DA. Baneiee CM. Birkkad NC, Grew CH. Scott SD, Haner 
WV. Effecls of carbon monoxide inhalation on ventricular fibrillation. 
Arch Environ Health 197~31:42-6. 
8. Amnm WS, Slemmcr EA. Wwd 8. cl at. Carbon monoxide and 
venticular hbrtltation threshold in dw with awe myacardial injury. Am 
Heart J 1978;95:754-6. 
9. Amraw WS, Harris CN. Irbetl MW. Rokow SN. Bffcct offreeway tmvcl 
an angina pcctooris. Ann ldem Med 1972:7X69-76. 
IO. K&w JH. United Statrr air quality criteria and ambient slandardp for 
carbon monoxide. UDI Bertchle NR 1972;180:99-101. 
I I. A,‘m SM. Evans RG. Buelcr ME. Th: prcv&ncc d carbaxylw,,oglo- 
bincmia in New Yorkers and the clfecls on the cornnary and dyswnic 
ckcutalion. Rev Med 1979;8:323-32. 
12. Hindertiler AL, Adams KPIr, Rice W. Herbst MC. Koch G. Skcps DS. 
El&& of low-level carbon monoxide exposure on resting and mxcise- 
induced ventricular arrhyihmias in patients with coronary artery disease 
and m baseline eclopy. Arch Emiza Health 1969?&?-93. 
13. Shcps US. Hefbst MC, Hinderliter AL, et al. Fwduction of arrhythmias 
by elevated carbaayhemoglobin in patienlr with coronary artery disease. 
Ann intern Med 19%;113:343-51. 
14. Dahms TE, Horvath SM. Rapid, accurate technique for dctcrmin&n of 
carban monoxide in bled. Clin Cbem 1974:20:533-7. 
15. Allred EN, Bleecka ER. Cbailman BR. et nl. Acute e,Tccc,s of carbon 
manoxide erpowe on individuals with coronary artery disease. Cam- 
bridpe. MA: Health Elects Institute, 1%9;25:ldP. 
16. Dahms TE, Horvath SM, Gnu DJ. Teclmiquc for s~cunrety pwducing 
desired carbaxybemc&bir. ~cvels during rwt and exercise. I Appl 
Pbysiol 3935;38;3@-8. 
17. Dixon WI, Bmm MB, Engelman L. Hill MA, Jrnmich RI. BMDP 
Statislical S-&we Manual. Berkeley. CA: University of California 
Press, 15%. 
IS. W&on RF. Slattstical Metbuds for the Analysis of B&medical Can. 
New York: John Wile:, & Sons. 1984. 
19. Vanoli E. Fanad GM, Siramba-Badialc M. Faber IF. Schwrtz PJ. 
Carhan momxidc and lethal arrhytbmiw in conrciou~ dogs with a healed 
myosudtl infarction. Am Hean J 1~9:117z348-57. 
20. Venia RL. Mills AK, Skomil WA. Acute effcct~ ofcarbon manonideon 
cmdlac slrctnsal stability. Cambridge. MA! Hcsllh EBccls InslituD. 
l9%:35:l-l4. 
21. Faster JR. Anhylbmogeaic e&us of carbon monoxide in experimental 
acute myocardial ischemia: lack of slowed conduclion and ventricular 
lachywdis. Am Heart J 1981:102:S76-82. 
22. AnusIaskwNana MI. Mentove RL Nanns JN. Andasw IL. Changer in 
s~ntmwous variability of ventricular ectopk activity as a fundion of 
time in patients dth chronic anhylhmiaJ. Cireutatin t98sp8:2&-95. 
23. Morsanrotb 1. Micbelaan E, HamwitzLN.loscphsonME. F&man AS. 
Dunkman WE. Liiitmianr of ronice long-term ctectmwd@rapldc 
monitoring to awas vrntrtculnr eclopic liequcncy. Circutaticn lP78;58: 
408-14. 
